| 0 |
EYE FLAT BLEB |
1 |
0.5000 |
| 1 |
ANGIOGRAM RETINA |
1 |
0.3333 |
| 2 |
WILLIAMS SYNDROME |
1 |
0.0417 |
| 3 |
PHOTOCOAGULATION |
1 |
0.0345 |
| 4 |
SUPRAVALVULAR AORTIC STENOSIS |
1 |
0.0294 |
| 5 |
RETINAL ARTERY STENOSIS |
1 |
0.0278 |
| 6 |
CAROTID PULSE ABNORMAL |
1 |
0.0185 |
| 7 |
HAEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS |
1 |
0.0137 |
| 8 |
HAEMANGIOMA CONGENITAL |
5 |
0.0105 |
| 9 |
ALPHA 2 GLOBULIN INCREASED |
1 |
0.0101 |
| 10 |
OXYGEN SATURATION IMMEASURABLE |
1 |
0.0091 |
| 11 |
LARYNX IRRITATION |
2 |
0.0085 |
| 12 |
RETINAL SCAR |
3 |
0.0065 |
| 13 |
POLYPOIDAL CHOROIDAL VASCULOPATHY |
2 |
0.0065 |
| 14 |
OPTIC DISC DISORDER |
1 |
0.0048 |
| 15 |
RETINAL ARTERY EMBOLISM |
1 |
0.0048 |
| 16 |
RETINAL OCCLUSIVE VASCULITIS |
1 |
0.0045 |
| 17 |
SURGICAL FAILURE |
5 |
0.0043 |
| 18 |
CORNEAL SCAR |
2 |
0.0040 |
| 19 |
MEAN ARTERIAL PRESSURE DECREASED |
1 |
0.0040 |
| 20 |
URTICARIA PAPULAR |
1 |
0.0039 |
| 21 |
BONE METABOLISM DISORDER |
1 |
0.0033 |
| 22 |
RETINAL ISCHAEMIA |
2 |
0.0033 |
| 23 |
CIRCUMORAL OEDEMA |
1 |
0.0029 |
| 24 |
KERATOCONJUNCTIVITIS SICCA |
1 |
0.0027 |
| 25 |
AGE-RELATED MACULAR DEGENERATION |
4 |
0.0026 |
| 26 |
PRODUCT BARCODE ISSUE |
1 |
0.0026 |
| 27 |
LARYNGEAL PAIN |
1 |
0.0025 |
| 28 |
CHOROIDAL NEOVASCULARISATION |
2 |
0.0023 |
| 29 |
SINUS RHYTHM |
1 |
0.0023 |
| 30 |
LENTICULAR OPACITIES |
1 |
0.0023 |
| 31 |
MEIBOMIAN GLAND DYSFUNCTION |
1 |
0.0022 |
| 32 |
CONTRAST MEDIA ALLERGY |
4 |
0.0022 |
| 33 |
CEREBRAL HYPOPERFUSION |
1 |
0.0021 |
| 34 |
VITREOUS DISORDER |
1 |
0.0021 |
| 35 |
PULSE PRESSURE DECREASED |
1 |
0.0020 |
| 36 |
PRODUCT CLOSURE ISSUE |
1 |
0.0018 |
| 37 |
ANTERIOR CHAMBER INFLAMMATION |
1 |
0.0017 |
| 38 |
ADRENAL ADENOMA |
1 |
0.0017 |
| 39 |
METAMORPHOPSIA |
3 |
0.0016 |
| 40 |
RETINAL OEDEMA |
3 |
0.0016 |
| 41 |
INCREASED VISCOSITY OF BRONCHIAL SECRETION |
1 |
0.0016 |
| 42 |
CORNEAL OPACITY |
2 |
0.0015 |
| 43 |
EPISCLERITIS |
1 |
0.0014 |
| 44 |
CRANIAL NERVE DISORDER |
1 |
0.0014 |
| 45 |
TONGUE PARALYSIS |
1 |
0.0014 |
| 46 |
DYSPNOEA PAROXYSMAL NOCTURNAL |
1 |
0.0014 |
| 47 |
COMA HEPATIC |
1 |
0.0013 |
| 48 |
HEART SOUNDS ABNORMAL |
1 |
0.0013 |
| 49 |
PATENT DUCTUS ARTERIOSUS |
5 |
0.0013 |
| 50 |
LYMPHOCYTE STIMULATION TEST POSITIVE |
1 |
0.0012 |
| 51 |
VITREOUS OPACITIES |
1 |
0.0012 |
| 52 |
MALIGNANT HYPERTENSION |
1 |
0.0012 |
| 53 |
CARDIAC OUTPUT DECREASED |
1 |
0.0011 |
| 54 |
ANAPHYLACTIC SHOCK |
29 |
0.0011 |
| 55 |
SKIN TEST POSITIVE |
1 |
0.0011 |
| 56 |
RETINAL EXUDATES |
1 |
0.0011 |
| 57 |
TONGUE INJURY |
1 |
0.0011 |
| 58 |
OCULAR HYPERTENSION |
2 |
0.0010 |
| 59 |
HAEMANGIOMA OF LIVER |
1 |
0.0010 |
| 60 |
GALLBLADDER ENLARGEMENT |
1 |
0.0009 |
| 61 |
PRODUCT NAME CONFUSION |
1 |
0.0009 |
| 62 |
IMMEDIATE POST-INJECTION REACTION |
1 |
0.0009 |
| 63 |
KOUNIS SYNDROME |
2 |
0.0009 |
| 64 |
SENSE OF OPPRESSION |
1 |
0.0008 |
| 65 |
HEPATITIS CHOLESTATIC |
5 |
0.0008 |
| 66 |
VENTRICULAR HYPERTROPHY |
2 |
0.0008 |
| 67 |
NECROTISING COLITIS |
1 |
0.0008 |
| 68 |
INTERCEPTED PRODUCT PRESCRIBING ERROR |
1 |
0.0008 |
| 69 |
CORNEAL ABRASION |
1 |
0.0007 |
| 70 |
VITREOUS HAEMORRHAGE |
2 |
0.0007 |
| 71 |
BLOOD PRESSURE IMMEASURABLE |
1 |
0.0007 |
| 72 |
LARYNGEAL OEDEMA |
4 |
0.0006 |
| 73 |
EYE ALLERGY |
1 |
0.0006 |
| 74 |
IDIOPATHIC THROMBOCYTOPENIC PURPURA |
1 |
0.0006 |
| 75 |
PULSE ABSENT |
3 |
0.0006 |
| 76 |
LOW BIRTH WEIGHT BABY |
5 |
0.0006 |
| 77 |
OPTIC ATROPHY |
1 |
0.0006 |
| 78 |
TROPONIN I INCREASED |
1 |
0.0006 |
| 79 |
MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED |
1 |
0.0006 |
| 80 |
MYOCARDIAL NECROSIS MARKER INCREASED |
1 |
0.0006 |
| 81 |
PAPULE |
4 |
0.0006 |
| 82 |
VOCAL CORD PARALYSIS |
1 |
0.0006 |
| 83 |
INTRAOCULAR PRESSURE INCREASED |
7 |
0.0005 |
| 84 |
CONDUCTION DISORDER |
1 |
0.0005 |
| 85 |
STENOSIS |
1 |
0.0005 |
| 86 |
EXTRAVASATION |
2 |
0.0005 |
| 87 |
ANAPHYLACTOID REACTION |
2 |
0.0005 |
| 88 |
TONGUE BITING |
1 |
0.0005 |
| 89 |
PULSELESS ELECTRICAL ACTIVITY |
2 |
0.0005 |
| 90 |
LANGUAGE DISORDER |
1 |
0.0005 |
| 91 |
VISUAL ACUITY REDUCED |
15 |
0.0005 |
| 92 |
CORNEAL OEDEMA |
1 |
0.0004 |
| 93 |
HAEMANGIOMA |
1 |
0.0004 |
| 94 |
CONTRAST MEDIA REACTION |
1 |
0.0004 |
| 95 |
RETINAL HAEMORRHAGE |
3 |
0.0004 |
| 96 |
GLOMERULONEPHRITIS |
1 |
0.0004 |
| 97 |
RETINAL ARTERY OCCLUSION |
1 |
0.0004 |
| 98 |
MYDRIASIS |
5 |
0.0004 |
| 99 |
APNOEA |
3 |
0.0004 |
| 100 |
RETINAL DISORDER |
1 |
0.0004 |
| 101 |
LARYNGOSPASM |
1 |
0.0004 |
| 102 |
ABDOMINAL RIGIDITY |
1 |
0.0004 |
| 103 |
TYPE IV HYPERSENSITIVITY REACTION |
1 |
0.0004 |
| 104 |
ACUTE PULMONARY OEDEMA |
2 |
0.0004 |
| 105 |
SKIN HYPERTROPHY |
1 |
0.0004 |
| 106 |
RENAL TUBULAR DISORDER |
1 |
0.0004 |
| 107 |
IMMUNE THROMBOCYTOPENIC PURPURA |
1 |
0.0004 |
| 108 |
RETINAL VEIN OCCLUSION |
1 |
0.0003 |
| 109 |
VOMITING PROJECTILE |
1 |
0.0003 |
| 110 |
COLD SWEAT |
6 |
0.0003 |
| 111 |
HYPERCAPNIA |
1 |
0.0003 |
| 112 |
FOREIGN BODY IN THROAT |
1 |
0.0003 |
| 113 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
1 |
0.0003 |
| 114 |
CARDIAC FAILURE ACUTE |
2 |
0.0003 |
| 115 |
TOXIC SKIN ERUPTION |
3 |
0.0003 |
| 116 |
HEPATIC CYST |
1 |
0.0003 |
| 117 |
SUDDEN CARDIAC DEATH |
1 |
0.0003 |
| 118 |
AORTIC STENOSIS |
1 |
0.0003 |
| 119 |
CAROTID ARTERY STENOSIS |
1 |
0.0003 |
| 120 |
TYPE I HYPERSENSITIVITY |
1 |
0.0003 |
| 121 |
HEART DISEASE CONGENITAL |
1 |
0.0003 |
| 122 |
CONJUNCTIVAL HYPERAEMIA |
1 |
0.0003 |
| 123 |
HYPOAESTHESIA ORAL |
4 |
0.0003 |
| 124 |
TONGUE OEDEMA |
1 |
0.0003 |
| 125 |
CONJUNCTIVAL HAEMORRHAGE |
1 |
0.0003 |
| 126 |
COMMUNICATION DISORDER |
1 |
0.0003 |
| 127 |
CYANOSIS |
4 |
0.0003 |
| 128 |
AZOTAEMIA |
1 |
0.0003 |
| 129 |
CREATININE RENAL CLEARANCE DECREASED |
1 |
0.0002 |
| 130 |
ENURESIS |
1 |
0.0002 |
| 131 |
LIP OEDEMA |
1 |
0.0002 |
| 132 |
ANAPHYLACTIC REACTION |
13 |
0.0002 |
| 133 |
UNRESPONSIVE TO STIMULI |
6 |
0.0002 |
| 134 |
PURPURA |
2 |
0.0002 |
| 135 |
OROPHARYNGEAL DISCOMFORT |
2 |
0.0002 |
| 136 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
1 |
0.0002 |
| 137 |
YELLOW SKIN |
1 |
0.0002 |
| 138 |
VITREOUS FLOATERS |
2 |
0.0002 |
| 139 |
DIABETIC NEUROPATHY |
1 |
0.0002 |
| 140 |
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED |
1 |
0.0002 |
| 141 |
PRODUCT COLOUR ISSUE |
1 |
0.0002 |
| 142 |
PERIPHERAL VASCULAR DISORDER |
1 |
0.0002 |
| 143 |
FOETAL DEATH |
1 |
0.0002 |
| 144 |
EYE DISCHARGE |
2 |
0.0002 |
| 145 |
NONSPECIFIC REACTION |
1 |
0.0002 |
| 146 |
BLOOD PRESSURE DECREASED |
12 |
0.0002 |
| 147 |
OBSTRUCTIVE AIRWAYS DISORDER |
2 |
0.0002 |
| 148 |
MACULAR OEDEMA |
1 |
0.0002 |
| 149 |
CIRCULATORY COLLAPSE |
3 |
0.0002 |
| 150 |
GENERALISED ERYTHEMA |
1 |
0.0002 |
| 151 |
CHEST DISCOMFORT |
18 |
0.0002 |
| 152 |
NEUROLOGICAL SYMPTOM |
1 |
0.0002 |
| 153 |
CARDIAC VALVE DISEASE |
1 |
0.0002 |
| 154 |
HYPOVOLAEMIA |
1 |
0.0002 |
| 155 |
INGUINAL HERNIA |
1 |
0.0002 |
| 156 |
PHOTOPSIA |
1 |
0.0002 |
| 157 |
GLAUCOMA |
3 |
0.0002 |
| 158 |
INCOHERENT |
1 |
0.0002 |
| 159 |
BRADYCARDIA |
8 |
0.0002 |
| 160 |
PALLOR |
4 |
0.0001 |
| 161 |
NEPHROTIC SYNDROME |
1 |
0.0001 |
| 162 |
ENCEPHALITIS |
1 |
0.0001 |
| 163 |
HEART RATE DECREASED |
5 |
0.0001 |
| 164 |
SNEEZING |
3 |
0.0001 |
| 165 |
HAEMODYNAMIC INSTABILITY |
1 |
0.0001 |
| 166 |
DISSOCIATION |
1 |
0.0001 |
| 167 |
ATRIOVENTRICULAR BLOCK |
1 |
0.0001 |
| 168 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
1 |
0.0001 |
| 169 |
PULMONARY HAEMORRHAGE |
1 |
0.0001 |
| 170 |
PRURITUS |
49 |
0.0001 |
| 171 |
ELECTROCARDIOGRAM ABNORMAL |
1 |
0.0001 |
| 172 |
RENAL CYST |
1 |
0.0001 |
| 173 |
RASH ERYTHEMATOUS |
6 |
0.0001 |
| 174 |
METABOLIC ACIDOSIS |
4 |
0.0001 |
| 175 |
HYPERHIDROSIS |
16 |
0.0001 |
| 176 |
PRESYNCOPE |
3 |
0.0001 |
| 177 |
POLYURIA |
1 |
0.0001 |
| 178 |
GENERALISED TONIC-CLONIC SEIZURE |
2 |
0.0001 |
| 179 |
SKIN SWELLING |
1 |
0.0001 |
| 180 |
URINE OUTPUT DECREASED |
1 |
0.0001 |
| 181 |
GROIN PAIN |
1 |
0.0001 |
| 182 |
PALPITATIONS |
13 |
0.0001 |
| 183 |
THROAT TIGHTNESS |
3 |
0.0001 |
| 184 |
CARDIAC ARREST |
9 |
0.0001 |
| 185 |
RETINAL DETACHMENT |
1 |
0.0001 |
| 186 |
URTICARIA |
18 |
0.0001 |
| 187 |
ARTERIOSCLEROSIS |
1 |
0.0001 |
| 188 |
EYE INFLAMMATION |
1 |
0.0001 |
| 189 |
HYPERCHOLESTEROLAEMIA |
1 |
0.0001 |
| 190 |
SINUS BRADYCARDIA |
1 |
0.0001 |
| 191 |
BODY TEMPERATURE DECREASED |
1 |
0.0001 |
| 192 |
LOSS OF CONSCIOUSNESS |
13 |
0.0001 |
| 193 |
URINARY INCONTINENCE |
3 |
0.0001 |
| 194 |
SALIVARY HYPERSECRETION |
1 |
0.0001 |
| 195 |
SYNCOPE |
10 |
0.0001 |
| 196 |
PETECHIAE |
1 |
0.0001 |
| 197 |
RETCHING |
2 |
0.0001 |
| 198 |
ANGIOEDEMA |
4 |
0.0001 |
| 199 |
HYPERTENSIVE CRISIS |
1 |
0.0001 |
| 200 |
HYPOTENSION |
18 |
0.0001 |
| 201 |
RASH PAPULAR |
2 |
0.0001 |
| 202 |
NEPHROPATHY TOXIC |
1 |
0.0001 |
| 203 |
OCULAR DISCOMFORT |
1 |
0.0001 |
| 204 |
MYOCARDIAL ISCHAEMIA |
1 |
0.0001 |
| 205 |
SKIN DISCOLOURATION |
4 |
0.0001 |
| 206 |
SHOCK |
2 |
0.0001 |
| 207 |
EYELID OEDEMA |
1 |
0.0001 |
| 208 |
SPLENOMEGALY |
1 |
0.0001 |
| 209 |
SPINAL PAIN |
1 |
0.0001 |
| 210 |
HYPOXIA |
3 |
0.0001 |
| 211 |
NEUROLEPTIC MALIGNANT SYNDROME |
1 |
0.0001 |
| 212 |
CHOLECYSTITIS |
1 |
0.0001 |
| 213 |
APPLICATION SITE IRRITATION |
1 |
0.0001 |
| 214 |
SECRETION DISCHARGE |
1 |
0.0001 |
| 215 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 216 |
CARDIOVASCULAR DISORDER |
2 |
0.0001 |
| 217 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
2 |
0.0001 |
| 218 |
HAEMATOMA |
2 |
0.0001 |
| 219 |
RASH |
33 |
0.0001 |
| 220 |
HYPERSENSITIVITY |
14 |
0.0001 |
| 221 |
EYE HAEMORRHAGE |
1 |
0.0001 |
| 222 |
CORONARY ARTERY OCCLUSION |
1 |
0.0001 |
| 223 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 224 |
RESPIRATORY ARREST |
2 |
0.0001 |
| 225 |
RESPIRATORY DISTRESS |
2 |
0.0001 |
| 226 |
ORAL DISCOMFORT |
1 |
0.0001 |
| 227 |
DISSEMINATED INTRAVASCULAR COAGULATION |
1 |
0.0001 |
| 228 |
HYPONATRAEMIA |
4 |
0.0001 |
| 229 |
EYE PAIN |
4 |
0.0001 |
| 230 |
HEPATOCELLULAR INJURY |
1 |
0.0001 |
| 231 |
SUBDURAL HAEMATOMA |
1 |
0.0001 |
| 232 |
ANGINA PECTORIS |
2 |
0.0001 |
| 233 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 234 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 235 |
CATARACT |
4 |
0.0001 |
| 236 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 237 |
THROAT IRRITATION |
3 |
0.0001 |
| 238 |
THERAPY NON-RESPONDER |
3 |
0.0001 |
| 239 |
TOXIC EPIDERMAL NECROLYSIS |
1 |
0.0001 |
| 240 |
PHARYNGEAL OEDEMA |
1 |
0.0001 |
| 241 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 242 |
ARRHYTHMIA |
3 |
0.0001 |
| 243 |
EYE DISORDER |
2 |
0.0001 |
| 244 |
CHILLS |
7 |
0.0001 |
| 245 |
EYE PRURITUS |
2 |
0.0001 |
| 246 |
VOMITING |
27 |
0.0001 |
| 247 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 248 |
DIABETES MELLITUS INADEQUATE CONTROL |
1 |
0.0001 |
| 249 |
DRUG ERUPTION |
1 |
0.0001 |
| 250 |
RASH PRURITIC |
3 |
0.0001 |
| 251 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 252 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 253 |
HEPATIC FUNCTION ABNORMAL |
2 |
0.0001 |
| 254 |
TUBULOINTERSTITIAL NEPHRITIS |
1 |
0.0001 |
| 255 |
HEPATIC CIRRHOSIS |
1 |
0.0001 |
| 256 |
DIZZINESS |
26 |
0.0001 |
| 257 |
DISEASE PROGRESSION |
6 |
0.0001 |
| 258 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 259 |
ABORTION SPONTANEOUS |
2 |
0.0000 |
| 260 |
VERTIGO |
3 |
0.0000 |
| 261 |
BLINDNESS |
2 |
0.0000 |
| 262 |
RIB FRACTURE |
1 |
0.0000 |
| 263 |
VISUAL IMPAIRMENT |
6 |
0.0000 |
| 264 |
CARDIO-RESPIRATORY ARREST |
2 |
0.0000 |
| 265 |
PRURITUS GENERALISED |
1 |
0.0000 |
| 266 |
SWELLING FACE |
3 |
0.0000 |
| 267 |
BLOOD PRESSURE INCREASED |
7 |
0.0000 |
| 268 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
0.0000 |
| 269 |
STEVENS-JOHNSON SYNDROME |
1 |
0.0000 |
| 270 |
TRANSAMINASES INCREASED |
1 |
0.0000 |
| 271 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 272 |
MATERNAL EXPOSURE DURING PREGNANCY |
4 |
0.0000 |
| 273 |
PANCREATITIS ACUTE |
1 |
0.0000 |
| 274 |
APPLICATION SITE PRURITUS |
1 |
0.0000 |
| 275 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 276 |
BURNING SENSATION |
3 |
0.0000 |
| 277 |
LIVER INJURY |
1 |
0.0000 |
| 278 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 279 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 280 |
HYPOAESTHESIA |
6 |
0.0000 |
| 281 |
FLUSHING |
4 |
0.0000 |
| 282 |
HEPATITIS |
1 |
0.0000 |
| 283 |
DRUG RESISTANCE |
1 |
0.0000 |
| 284 |
NAUSEA |
30 |
0.0000 |
| 285 |
FEAR |
1 |
0.0000 |
| 286 |
CONFUSIONAL STATE |
6 |
0.0000 |
| 287 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 288 |
PRODUCT QUALITY ISSUE |
5 |
0.0000 |
| 289 |
FEELING COLD |
1 |
0.0000 |
| 290 |
DEMENTIA |
1 |
0.0000 |
| 291 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1 |
0.0000 |
| 292 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 293 |
CONVULSION |
2 |
0.0000 |
| 294 |
HYPERSOMNIA |
1 |
0.0000 |
| 295 |
SEIZURE |
4 |
0.0000 |
| 296 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 297 |
RENAL INJURY |
1 |
0.0000 |
| 298 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 299 |
HEPATIC FAILURE |
1 |
0.0000 |
| 300 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 301 |
FEELING HOT |
2 |
0.0000 |
| 302 |
DYSPNOEA |
18 |
0.0000 |
| 303 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 304 |
ATRIAL FIBRILLATION |
3 |
0.0000 |
| 305 |
CHOLELITHIASIS |
1 |
0.0000 |
| 306 |
HEART RATE INCREASED |
3 |
0.0000 |
| 307 |
RENAL FAILURE |
4 |
0.0000 |
| 308 |
SKIN DISORDER |
1 |
0.0000 |
| 309 |
HEPATIC ENZYME INCREASED |
2 |
0.0000 |
| 310 |
HYPERKALAEMIA |
1 |
0.0000 |
| 311 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
2 |
0.0000 |
| 312 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 313 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
0.0000 |
| 314 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 315 |
RESTLESSNESS |
1 |
0.0000 |
| 316 |
DYSARTHRIA |
1 |
0.0000 |
| 317 |
ABDOMINAL PAIN |
6 |
0.0000 |
| 318 |
RENAL IMPAIRMENT |
2 |
0.0000 |
| 319 |
SEPTIC SHOCK |
1 |
0.0000 |
| 320 |
MENTAL DISORDER |
1 |
0.0000 |
| 321 |
LIVER DISORDER |
1 |
0.0000 |
| 322 |
TACHYCARDIA |
2 |
0.0000 |
| 323 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 324 |
CHEST PAIN |
4 |
0.0000 |
| 325 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 326 |
SWELLING |
2 |
0.0000 |
| 327 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 328 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 329 |
CONTUSION |
2 |
0.0000 |
| 330 |
DRY EYE |
1 |
0.0000 |
| 331 |
CELLULITIS |
1 |
0.0000 |
| 332 |
ERYTHEMA |
4 |
0.0000 |
| 333 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 334 |
HAEMORRHAGE |
2 |
0.0000 |
| 335 |
ECZEMA |
1 |
0.0000 |
| 336 |
SPEECH DISORDER |
1 |
0.0000 |
| 337 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 338 |
ASTHENIA |
7 |
0.0000 |
| 339 |
OEDEMA |
1 |
0.0000 |
| 340 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 341 |
MEDICATION ERROR |
1 |
0.0000 |
| 342 |
NECK PAIN |
1 |
0.0000 |
| 343 |
ABDOMINAL DISCOMFORT |
3 |
0.0000 |
| 344 |
COUGH |
5 |
0.0000 |
| 345 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 346 |
LETHARGY |
1 |
0.0000 |
| 347 |
DYSPHONIA |
1 |
0.0000 |
| 348 |
DISCOMFORT |
1 |
0.0000 |
| 349 |
MUSCLE SPASMS |
3 |
0.0000 |
| 350 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 351 |
MALAISE |
7 |
0.0000 |
| 352 |
VISION BLURRED |
2 |
0.0000 |
| 353 |
HYPERTENSION |
3 |
0.0000 |
| 354 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 355 |
AGITATION |
1 |
0.0000 |
| 356 |
HALLUCINATION |
1 |
0.0000 |
| 357 |
HOT FLUSH |
1 |
0.0000 |
| 358 |
ACUTE KIDNEY INJURY |
2 |
0.0000 |
| 359 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 360 |
HEADACHE |
8 |
0.0000 |
| 361 |
PARAESTHESIA |
2 |
0.0000 |
| 362 |
CARDIAC FAILURE |
1 |
0.0000 |
| 363 |
FOETAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 364 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 365 |
CEREBROVASCULAR ACCIDENT |
2 |
0.0000 |
| 366 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 367 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 368 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 369 |
PRODUCT USE ISSUE |
2 |
0.0000 |
| 370 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 371 |
OFF LABEL USE |
9 |
0.0000 |
| 372 |
DYSPEPSIA |
1 |
0.0000 |
| 373 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 374 |
ABDOMINAL PAIN UPPER |
2 |
0.0000 |
| 375 |
SEPSIS |
1 |
0.0000 |
| 376 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 377 |
ASTHMA |
1 |
0.0000 |
| 378 |
PYREXIA |
3 |
0.0000 |
| 379 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 380 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
0.0000 |
| 381 |
FATIGUE |
6 |
0.0000 |
| 382 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 383 |
DRUG INTERACTION |
1 |
0.0000 |
| 384 |
PNEUMONIA |
2 |
0.0000 |
| 385 |
TREMOR |
1 |
0.0000 |
| 386 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 387 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 388 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 389 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 390 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 391 |
ANAEMIA |
1 |
0.0000 |
| 392 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 393 |
SOMNOLENCE |
1 |
0.0000 |
| 394 |
DIARRHOEA |
3 |
0.0000 |
| 395 |
BACK PAIN |
1 |
0.0000 |
| 396 |
DEATH |
3 |
0.0000 |
| 397 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 398 |
PAIN |
1 |
0.0000 |
| 399 |
DRUG INEFFECTIVE |
2 |
0.0000 |